SLC7A11 and neoplasm: In the above-mentioned pathways, STAT1 is activated and translocated to the nucleus in the form of a dimer that acts as a transcriptional repressor, inhibiting SLC7A11 and SLC3A2 expression, and thus reducing the resistance of tumor cells to lipid peroxidation[86–87].